Clinical trials

  • BENRALIZUMAB for Eosinophilic granulomatosis with polyangiitis (EGPA)
  • RAPCABTAGENE AUTOLEUCEL for Systemic lupus erythematosus | Lupus nephritis
  • UPADACITINIB for Psoriatic arthritis|Axial spondyloarthritis
  • 3-(2,6-DICHLOROPHENYL)-2,3-DIHYDRO-1-METHYL-7-[[3-METHYL-4-(1-METHYL-4-PIPERIDINYL)PHENYL]AMINO]-PYRIMIDO[4,5-D]PYRIMIDIN-4(1H)-ONE for Advanced solid tumours (CCNE1 amplification or deleterious mutations in FBXW7 or other proprietary gene)
  • Venetoclax for Acute myeloid leukemia secondary to myeloproliferative neoplasms
  • Allergenic extract of grass pollen mixture (Dactylis glomerata, Festuca pratensis, Lolium perenne, Phleum pratense and Poa pratensis), polymerised for Allergic rhinoconjunctivitis (grass pollen allergy)|Seasonal allergy (grass pollen)
  • PONATINIB for BCR/ABL1-like acute lymphoblastic leukemia (Philadelphia chromosome-negative)
  • CAPECITABINE for Gastrointestinal cancer | Colon cancer | Colorectal cancer
  • MESENCHYMAL STROMAL CELLS, EX VIVO CULTURED for Multiple sclerosis | Primary progressive multiple sclerosis | Secondary progressive multiple sclerosis
  • 7,8-DIBROMO-5,6-DIHYDRO-9-METHYL-2-(1-PIPERAZINYL)-4H-IMIDAZO[4,5,1-IJ]QUINOLINE HYDROCHLORIDE for Myelodysplastic syndromes (MDS), lower-risk, with symptomatic anemia
  • PARIGLASGENE BRECAPARVOVEC for Glycogen storage disease type Ia (GSDIa)
  • ZP9830 for Autoimmune diseases